Jazz Pharmaceuticals

Gastroesophageal adenocarcinoma (GEA) is a challenging cancer to treat. The page features stories, perspectives and resources about the disease and efforts to advance care.

Jazz Pharmaceuticals says patient safety is of paramount importance and directs people to contact a physician to report an adverse event or ask questions about their condition.

Healthcare professionals and patients may request product information from Jazz Pharmaceuticals’ Medical Information Department, which does not advise on individual medical questions. The page also provides information about Expanded Access.

Jazz Pharmaceuticals has a diverse portfolio of meaningful products that address unmet medical needs in sleep and hematology/oncology.

Jazz Pharmaceuticals develops medicines for people with rare diseases and limited or no therapeutic options. It also supports external investigators, organizations and institutions proposing scientific research for which they serve as study sponsor.

Patients, families, clinicians and advocates play vital roles in rare cancer research. The page says meaningful breakthroughs in rare cancers are not achieved alone.

Jazz Pharmaceuticals supports clinical knowledge generated through research, including non-interventional studies, which follow applicable regulations, industry practices and internal policies. It cites transparency and reproducibility as standards supporting the integrity of sponsored research.

Narcolepsy is a chronic neurological disorder marked by disrupted nighttime sleep, excessive daytime sleepiness and cataplexy. The company partners with organizations such as Wake Up Narcolepsy to connect research with lived experience and advance whole-person care.

Jazz launched Pioneering Pathways to showcase people and research behind its scientific approach. The inaugural episode focuses on idiopathic hypersomnia and features perspectives from the community.

Jazz warns of fraudulent schemes involving its name and recruitment. It says it will not make job offers by text, request sensitive personal or bank information through the stated channels, or require candidates to send money to apply or receive an offer.

Jazz Pharmaceuticals’ Board of Directors provides leadership and guidance for the company’s mission.

Jazz's leadership has a proven track record of developing and commercializing therapeutics, creating programs for patients, and driving shareholder value.

Jazz Pharmaceuticals seeks opportunities to acquire or in-license highly differentiated commercial, near-commercial and development-stage products.

Jazz's commitment to patients extends beyond delivering critical medications. It also includes acting responsibly, safely and with transparency.

Jazz’s medicines are available in nearly 100 countries. Its global commercial footprint and operations support the advancement and delivery of its medicines.

Jazz Pharmaceuticals was founded with a simple goal: to create a company with a constant focus on patients that is a great place to work.

The page provides information about Jazz’s locations in the US and Europe.

Jazz Pharmaceuticals is focused on improving patients’ lives by identifying, developing, and commercializing products that address unmet medical needs.

The Terms of Use govern access to and use of the website.